FDA Import Refusal AEK-9375889-2/20003/1 — EXEMED PHARMACUTICALS
The FDA refused shipment AEK-9375889-2/20003/1 from EXEMED PHARMACUTICALS (India) on Feb 10, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Feb 10, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75